Category: 805250-17-3

Synthetic Route of 805250-17-3, The reaction rate of a catalyzed reaction is faster than the reaction rate of the uncatalyzed reaction at the same temperature.805250-17-3, Name is Methyl 2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate, molecular formula is C11H12O4. In a Article，once mentioned of 805250-17-3

The mass spectrometric behaviour of four 2,3-dihydro-1-benzofuran-3-acetic acids has been studied in detail with the aid of exact mass measurements, linked scans, collisionally activated decomposition, mass analysed ion kinetic energy spectra and labelling experiments.Unusual fragmentation pathways are emphasized for which mechanisms are proposed.

We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 805250-17-3, and how the biochemistry of the body works.Synthetic Route of 805250-17-3

Reference：
Benzofuran – Wikipedia,
Benzofuran | C8H3558O – PubChem

Application of 805250-17-3, Chemistry is the science of change. But why do chemical reactions take place? Why do chemicals react with each other? The answer is in thermodynamics and kinetics.In a document type is Patent, and a compound is mentioned, 805250-17-3, Methyl 2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate, introducing its new discovery.

The present invention relates to compounds of general formula I, wherein the group (Het)Ar is defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Application of 805250-17-3. In my other articles, you can also check out more blogs about 805250-17-3

Reference：
Benzofuran – Wikipedia,
Benzofuran | C8H3537O – PubChem

Application of 805250-17-3, The reaction rate of a catalyzed reaction is faster than the reaction rate of the uncatalyzed reaction at the same temperature.805250-17-3, Name is Methyl 2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate, molecular formula is C11H12O4. In a Patent，once mentioned of 805250-17-3

The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the description, or a salt thereof. The compound or a salt thereof or a prodrug thereof has a GPR40 receptor function modulating action and is useful as an insulin secretagogue or an agent for the prophylaxis or treatment of diabetes and the like.

We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 805250-17-3, and how the biochemistry of the body works.Application of 805250-17-3

Reference：
Benzofuran – Wikipedia,
Benzofuran | C8H3556O – PubChem

805250-17-3, Name is Methyl 2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate, belongs to benzofurans compound, is a common compound. SDS of cas: 805250-17-3In an article, once mentioned the new application about 805250-17-3.

The present invention relates to compounds of general formula (I), wherein the groups R1, R2 and m are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.

Do you like my blog? If you like, you can also browse other articles about this kind. Thanks for taking the time to read the blog about 805250-17-3

Reference：
Benzofuran – Wikipedia,
Benzofuran | C8H3533O – PubChem

Chemistry is an experimental science, and the best way to enjoy it and learn about it is performing experiments. Product Details of 805250-17-3. Introducing a new discovery about 805250-17-3, Name is Methyl 2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate

The invention belongs to the field of medicine technology, and specifically relates to an aromatic polycyclic carboxylic acid derivative GPR40 receptor agonist with a general formula (I), a pharmaceutically acceptable salt thereof, and an ester or stereoisomer thereof, wherein R1, R2, R3, R4, R5 and X are as defined in the specification. The invention also relates to preparation methods of the compounds, pharmaceutical preparation and pharmaceutical composition, as well as application of the compound and the pharmaceutical composition as the GPR40 receptor agonist to preparation of drugs for prevention and / or treatment of diabetes.

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.Product Details of 805250-17-3, you can also check out more blogs about805250-17-3

Reference：
Benzofuran – Wikipedia,
Benzofuran | C8H3552O – PubChem

Related Products of 805250-17-3, Chemistry is the science of change. But why do chemical reactions take place? Why do chemicals react with each other? The answer is in thermodynamics and kinetics.In a document type is Patent, and a compound is mentioned, 805250-17-3, Methyl 2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate, introducing its new discovery.

Compounds of general formula I wherein the group R1 is defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Related Products of 805250-17-3. In my other articles, you can also check out more blogs about 805250-17-3

Reference：
Benzofuran – Wikipedia,
Benzofuran | C8H3532O – PubChem

Electric Literature of 805250-17-3, Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In some cases, the catalyzed mechanism may include additional steps.In a article, 805250-17-3, molcular formula is C11H12O4, introducing its new discovery.

The invention discloses a 2 – (6 – hydroxy – 2, 3 – dihydrobenzofuran – 3 – yl) acetic acid methyl ester of the chiral separation method, the method to sulfonic acid – beta – cyclodextrin as selective agent, sodium tetraborate as damping fluid, under the action of cyclodextrin in the sulfonic acid – beta -, through the capillary electrophoresis chromatography to realize the enantiomers of baseline separation. The invention has simple operation, analysis time is short, the used reagent consumption and does not pollute the environment, can be used for the rapid detection of optical purity of the compound. (by machine translation)

The proportionality constant is the rate constant for the particular unimolecular reaction. the reaction rate is directly proportional to the concentration of the reactant. I hope my blog about 805250-17-3 is helpful to your research. Electric Literature of 805250-17-3

Reference：
Benzofuran – Wikipedia,
Benzofuran | C8H3554O – PubChem

Chemistry is traditionally divided into organic and inorganic chemistry. name: Methyl 2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate, The former is the study of compounds containing at least one carbon-hydrogen bonds.In a patent，Which mentioned a new discovery about 805250-17-3

A fused heterocyclic compound having an enteropeptidase inhibitory action and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided. Specifically, a compound represented by the following formula (I): wherein each symbol is as defined herein, or a salt thereof and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided.

If you are interested in 805250-17-3, you can contact me at any time and look forward to more communication. name: Methyl 2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate

Reference：
Benzofuran – Wikipedia,
Benzofuran | C8H3543O – PubChem

Electric Literature of 805250-17-3, The reaction rate of a catalyzed reaction is faster than the reaction rate of the uncatalyzed reaction at the same temperature.805250-17-3, Name is Methyl 2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate, molecular formula is C11H12O4. In a Patent，once mentioned of 805250-17-3

The invention relates to a benzodioxane derivative, a preparation method thereof and application of the derivative in medicines. Specifically, the invention relates to a novel benzodioxane derivative shown as a formula (I), medial salt thereof or a medicine composition containing the derivative, and a preparation method of the derivative. The invention further relates to a use of the benzodioxane derivative and the medial salt thereof or the medicine composition containing the derivative in preparing therapeutic agent, especially GPR 40 agonist, and a drug for treating the diseases such as diabetes, metabolic disorders and the like, wherein each substituent group in the formula (I) is as defined in the description.

A reaction mechanism is the microscopic path by which reactants are transformed into products. Each step is an elementary reaction. In my other articles, you can also check out more blogs about 805250-17-3

Reference：
Benzofuran – Wikipedia,
Benzofuran | C8H3546O – PubChem

Related Products of 805250-17-3, Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In some cases, the catalyzed mechanism may include additional steps.In a article, 805250-17-3, molcular formula is C11H12O4, introducing its new discovery.

The free fatty acid receptor 1 (FFA1) and peroxisome proliferator-activated receptors (PPARs) have attracted interest as potent targets for the treatment of metabolic syndrome such as type 2 diabetes. Based on the hypothesis that the dual agonists of PPARs and FFA1 would act as insulin sensitizers and secretagogues by simultaneous activation of PPARs and FFA1, we developed the design strategy to obtain dual PPARs/FFA1 agonist by hybrid FFA1 agonist 1 with PPARdelta agonist 2 in consideration of their structural similarity. As expected, systematic exploration of structure-activity relationship and molecular modeling, results in the discovery of lead compound 15, a pan agonist with relative balanced activities between FFA1, PPARgamma and PPARdelta. The dose-response relationship studies suggested that the pan agonist 15 suppressed the excursion of blood glucose levels in a dose-dependent manner. During a 5-days treatment in ob/ob mice, the pan agonist 15 (100 mg/kg) revealed sustained hypoglycemic effect, even proximity to the most advanced FFA1 agonist (TAK-875, 40 mg/kg), which might be attributed to its pan PPARs/FFA1 activities to simultaneous regulate the mechanism of insulin secretion and resistance. These positive results suggest that the dual PPARs/FFA1 agonists such as lead compound 15 might be novel therapeutic strategy to modulate the complex pathological mechanisms of type 2 diabetes.

The proportionality constant is the rate constant for the particular unimolecular reaction. the reaction rate is directly proportional to the concentration of the reactant. I hope my blog about 805250-17-3 is helpful to your research. Related Products of 805250-17-3

Reference：
Benzofuran – Wikipedia,
Benzofuran | C8H3566O – PubChem